Rebecca Frey is a versatile enterprise leader and experienced biopharma executive with twenty years of professional experience. She has expertise across most disciplines required to bring drugs to market – clinical development, medical affairs, program management, M&A, strategic planning, change management and manufacturing. As a strategic thinker and an agile leader, she is adept at preparing board-level strategies and managing cross-functional teams. Communication and partnership are also key aspects of her leadership style.
As the chief operating officer at Cardurion Pharmaceuticals, Rebecca is overseeing all aspects of company operations for the start-up that is developing novel therapies for cardiovascular diseases.
Rebecca was previously the executive vice president of operations for Prevail Therapeutics, a start-up developing gene therapy products for neurodegenerative diseases. In this capacity, Rebecca was a member of the executive team. She managed operations for a lead preclinical program, contributed to the development of strategy and supported the company’s efforts to build infrastructure during its first year of operations.
Prior to Prevail, Rebecca was vice president of operations & portfolio management at Alexion Pharmaceuticals (NASDAQ: ALXN). During her eleven year tenure at Alexion Rebecca held positions of increasing responsibility in multiple business areas, including medical affairs, program management, corporate development, manufacturing, operations strategy and real estate. Among her accomplishments, Rebecca led multiple successful integrations and development programs, and also served as a chief of staff to the CEO.
Prior to Alexion, Rebecca spent six years at Novartis Pharmaceuticals in clinical development and medical affairs. She also worked previously in academia as an assistant professor of pharmacy at Northeastern University. She now serves as a member of the Dean’s Advisory Board for the UConn School of Pharmacy.
Rebecca holds a Doctor of Pharmacy degree and a postgraduate clinical research fellowship from Northeastern University. Rebecca was selected to participate in the Women in Bio Boardroom Ready program* and is a member of the 2017 class. Rebecca resides in Connecticut with her husband and their three children.